FY2025 · ended Dec 31, 2025 · Revenue $81.46M, +26.4% YoY · Filed Mar 31, 2026
Fitlife Brands, Inc. (FTLF) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $81.5 million and net income of $6.3 million. Free cash flow was $7.4 million. As of Jun 30, 2026 it held $1.1 million in cash and investments and $495,000 in total debt.
Revenue (TTM)
$35.75M
-43.3% vs year-ago TTM
Net income (TTM)
$1.92M
-75.8% vs year-ago TTM
Operating cash flow (TTM)
$10.04M
+53.7% vs year-ago TTM
Free cash flow (TTM)
$10.02M
+54.2% vs year-ago TTM
EPS (TTM)
$0.19
-75.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
9.39M
+0.0% vs prior year
Net cash
$594,000
as of Jun 30, 2026
Operating margin
10.9%
FY 2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- FTLF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Omaha, NE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374328
- Former names
- BOND LABORATORIES, INC. (until Oct 1, 2013)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $81.5M | $64.5M | $52.7M | $28.8M | $27.9M |
| Operating income | $10.1M | $13.1M | $7.5M | $5.7M | $6.2M |
| Net income | $6.3M | $9.0M | $5.3M | $4.4M | $5.4M |
| Diluted EPS | $0.63 | $0.91 | $0.54 | $0.89 | $1.13 |
| Operating cash flow | $7.4M | $9.6M | $4.2M | $4.1M | $4.5M |
| Free cash flow | $7.4M | $9.6M | $4.1M | — | — |
| Total assets | $106.3M | $58.5M | $55.3M | $25.7M | $21.5M |
| Total liabilities | $62.7M | $22.4M | $28.3M | $4.3M | $4.2M |
| Stockholders' equity | $43.6M | $36.1M | $27.0M | $21.4M | $17.3M |
| Cash and investments | $1.6M | $4.5M | $1.1M | $13.3M | $9.9M |
| Total debt | $705,000 | $13.5M | $20.3M | $103,000 | $158,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
|
Aug 13, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 18, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
All 539 Fitlife Brands, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.